Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis
暂无分享，去创建一个
R. Fumagalli | F. Colombo | P. Tarsia | O. Epis | C. Perno | M. Puoti | M. Bottiroli | M. Mondino | G. Travi | A. Bellone | R. Rossotti | M. Merli | M. Corradin | N. Ughi | S. Pastori | M. Moreno | C. Baiguera | R. Ruggeri | Andriano Basile